TelyRx Holdings Inc. recorded two insider trading transactions during June 2026. Director Robert Sean Foley executed consecutive open market purchases totaling 45,770 CAD. These acquisitions involved 19,900 shares acquired across two days. No divestments occurred within this period, reflecting a singular focus on increasing equity positions by this board member.